Capital Advisors Inc. OK decreased its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,225 shares of the pharmacy operator’s stock after selling 486 shares during the quarter. Capital Advisors Inc. OK’s holdings in CVS Health were worth $683,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. AMF Tjanstepension AB increased its stake in CVS Health by 124.1% in the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock valued at $3,882,000 after acquiring an additional 34,198 shares during the last quarter. Exchange Traded Concepts LLC increased its stake in shares of CVS Health by 61.9% in the 3rd quarter. Exchange Traded Concepts LLC now owns 14,853 shares of the pharmacy operator’s stock valued at $934,000 after purchasing an additional 5,679 shares during the last quarter. Procyon Advisors LLC bought a new stake in shares of CVS Health during the 3rd quarter worth $202,000. CX Institutional boosted its stake in CVS Health by 698.0% in the third quarter. CX Institutional now owns 74,609 shares of the pharmacy operator’s stock valued at $4,691,000 after buying an additional 65,259 shares in the last quarter. Finally, Creative Planning raised its stake in CVS Health by 23.5% during the third quarter. Creative Planning now owns 250,891 shares of the pharmacy operator’s stock worth $15,776,000 after acquiring an additional 47,737 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on the stock. Leerink Partners lifted their price target on shares of CVS Health from $51.00 to $55.00 and gave the company a “market perform” rating in a report on Tuesday. Wolfe Research upped their price target on shares of CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a report on Tuesday. TD Cowen raised their price objective on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a report on Monday, November 25th. Truist Financial lowered their target price on CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $67.78.
CVS Health Stock Performance
Shares of CVS Health stock opened at $63.23 on Thursday. The company has a market cap of $79.57 billion, a P/E ratio of 16.05, a PEG ratio of 0.60 and a beta of 0.61. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The business has a 50-day moving average price of $50.61 and a two-hundred day moving average price of $55.92. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75.
CVS Health (NYSE:CVS – Get Free Report) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. As a group, analysts anticipate that CVS Health Co. will post 5.14 EPS for the current year.
CVS Health Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.21%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is currently 67.51%.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Recommended Stories
- Five stocks we like better than CVS Health
- Investing In Automotive Stocks
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- How to Buy Cheap Stocks Step by Step
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Buy P&G Now, Before It Sets A New All-Time High
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.